Search

everythinglearnresearchcommunity

for

Search:↓

The dog with an Alopecia Areata-like condition showed signs of an autoimmune disease and partially regrew hair without treatment, suggesting dogs could be models for human AA research.

A man developed a skin cancer called folliculotropic mycosis fungoides after a kidney transplant.

Permanent hair dye may cause total hair loss.

A woman developed alopecia after her second Pfizer vaccine but regrew her hair with treatment and had no issues after a booster shot.

A woman's hair loss, resembling an autoimmune condition, improved after treatment, but requires ongoing checks due to potential serious associations.

Biopsy can differentiate between alopecia areata and androgenic alopecia, and if more information is needed, testing for CD3 and CD8 can help.

Curcumin applied to the skin can start hair growth in mice.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

Targeting CXCL10 may help treat alopecia areata.

The conclusion is that a new method could improve the identification of autoimmune targets in alopecia areata, despite some limitations.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Tofacitinib may be an effective and safe treatment for adolescent alopecia areata.

Understanding the genetics of alopecia areata could lead to better treatments.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Nitric oxide is important for skin functions and both helps protect against and contributes to skin inflammation and sensitization.

New treatments and strategies are needed for Alopecia Areata, focusing on immune response and better trial designs.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

A young child with complete hair loss improved significantly with a combination of hair growth treatments and laser therapy.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

JAK inhibitors may help treat alopecia areata and promote hair regrowth.

Loss of the Y chromosome and UTY gene activity increases cancer risk in men.

The study suggests that hypothyroidism may cause alopecia areata.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

Inflammation in hair follicles is a key risk factor for developing common baldness.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

A woman's progressive hair loss was correctly diagnosed as a rare condition called fibrosing alopecia in a pattern distribution after initially being mistaken for a more common type.

IL-33 is linked to hair follicle damage in psoriasis and could be a treatment target for hair loss in this condition.

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

The document explains how the immune system reacts to organ transplants and the treatments used to prevent rejection.